Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2021

Pfizer Oncology - Expert Perspectives in ALK+NSCLC: a round table discussion

Treatment selection and sequencing: decision making in 2021

Date

18 Sep 2021

Session

Pfizer Oncology - Expert Perspectives in ALK+NSCLC: a round table discussion

Topics

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Todd Bauer

Authors

T.M. Bauer

Author affiliations

  • Medical Oncology, Sarah Cannon Research Institute/Tennessee Oncology, PLLC, 37203 - Nashville/US

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Welcome and introduction

Presenter: Nicolas Girard

Session: Pfizer Oncology - Expert Perspectives in ALK+NSCLC: a round table discussion

Resources:

Webcast

Recent advances in ALK+ NSCLC

Presenter: Ben Solomon

Session: Pfizer Oncology - Expert Perspectives in ALK+NSCLC: a round table discussion

Resources:

Webcast

Q+A session

Presenter: Ibiayi Dagogo-Jack

Session: Pfizer Oncology - Expert Perspectives in ALK+NSCLC: a round table discussion

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.